Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Mantle cell lymphoma (MCL) is biologically and clinically heterogeneous and would benefit from prognostic biomarkers to guide management. Circulating tumor DNA (ctDNA) is a novel prognostic biomarker in diffuse large B-cell lymphoma that may have applicability in MCL. We analyzed ctDNA dynamics in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhotia, Rahul, Melani, Christopher, Dunleavy, Kieron, Pittaluga, Stefania, Saba, Nakhle, Lindenberg, Liza, Mena, Esther, Bergvall, Ethan, Lucas, Andrea Nicole, Jacob, Allison, Yusko, Erik, Steinberg, Seth M., Jaffe, Elaine S., Wiestner, Adrian, Wilson, Wyndham H., Roschewski, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043939/
https://www.ncbi.nlm.nih.gov/pubmed/35143622
http://dx.doi.org/10.1182/bloodadvances.2021006397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043939/
https://www.ncbi.nlm.nih.gov/pubmed/35143622
http://dx.doi.org/10.1182/bloodadvances.2021006397

Ejemplares similares